Abstract Submission
  • /
  • Abstracts

abstract submission guidelines

The Scientific Committee of the Asian Society for Neuro-Oncology (ASNO) 2027 invites the submission of abstracts for oral and poster presentations. All abstracts must be submitted in English language via the online submission system.

1. Timelines
  • Submission Opens – 20th August 2026
  • Abstract Submission Deadline – 15th November 2026

2. Abstract types
  • Podium (Oral) Presentation
  • Mini Oral
  • Poster Presentation
  • No Preference

3. Abstract Categories

Category A – Basic/Translational Neuro-Oncology

  • Angiogenesis & Invasion
  • Cell Biology / Metabolism / Stem Cells
  • Signalling Pathways / Drug Resistance
  • Genetics / Epigenetics
  • Experimental Therapeutics / Preclinical Studies
  • Tumour Biology / Models
  • Immunology / Tumour Immunology
  • Drug discovery pathways
  • Microbiome analysis

Category B – Clinical Neuro-Oncology

  • Adult Neuro-Oncology - Clinical Trials / Therapeutic Studies
  • Paediatric Neuro-Oncology - Clinical Trials / Therapeutic Studies
  • TYA/AYA Neuro-Oncology – Clinical Trials / Therapeutic Studies
  • Neuro-Surgical / Intraoperative Therapy / Mapping & Monitoring
  • Radiation Therapy including Particle Beam Therapy
  • Systemic Therapy - Chemotherapy/ Targeted Therapy/ Immunotherapy
  • Molecular Pathology / Classification / Biomarkers
  • Next generation sequencing (NGS) / DNA methylation
  • Neuroimaging including Radiomics/Radiogenomics & AI, ML, DL
  • Neuro-Cognition / Quality of Life / Palliative Care

Category C – Cross-cutting and off-beat Themes

  • Survivorship & Return to Work/Education
  • Health Services / Quality Improvement / Health Technology Assessments (HTA)
  • Epidemiology / Outcomes Research
  • Health Disparities / Equity
  • Patient Advocacy

Please note that the acceptance or rejection of submitted abstracts as well as the presentation format is at the sole discretion of the Scientific Committee.

4. Abstract format
  • Title: Up to 100 characters (no abbreviations or punctuation marks recommended)
  • Length: 300 words
  • Abstract Body: Background/Aim, Methods, Results, Conclusion
  • Figures/Tables: 1 is allowed
  • Keywords: 3–5 words

Please note that the abstract will be published as submitted. We kindly ask you to carefully check for any typographical or grammatical errors before submission.

5. Ethical and scientific considerations

All studies involving human subjects or animals must have received appropriate ethical approval at the respective institution. Case reports should ensure patient anonymity. The presenting author must disclose any Conflict of Interest (COI) relevant to the submitted work at the time of conference presentation.


6. Review Process

All abstracts will be peer-reviewed by members of the Scientific Committee under a double-blind review system. Evaluation criteria include: Scientific quality, Originality, Clarity of presentation, Relevance to neuro-oncology.


7. Notification and Publication

Notification of acceptance, presentation format, and schedule will be sent to the submitting/presenting author via e-mail by 15th December 2026. No corrections or revisions will be accepted after the submission deadline.


8. Submission

You may revise or delete your submitted abstract as many times as necessary before the submission deadline. No changes can be made after the deadline.

CREATE PROFILE

Haven’t created the profile yet?
Please visit the below link to create profile and submit abstract.

CLICK HERE TO CREATE PROFILE

SUBMIT ABSTRACT

Have you registered for conference or created your profile?
If yes, you can submit abstract by visiting the following link.

CLICK HERE TO SUBMIT ABSTRACT